MediciNova, Inc. (MNOV) Social Stream
MEDICINOVA INC (MNOV) Price Targets From Analysts
Use the tables below to see what analysts covering MEDICINOVA INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 31 months, MNOV's average price target has gone down $5.32.
Over the past 47 weeks, MNOV's average upside potential has been 462.68%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MNOV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MNOV's average broker recommendation rating improved by 0 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how MEDICINOVA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 43.02% of that group.
- In terms of how MEDICINOVA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -652.56% of that group.
- In the context of stocks in the small market cap category, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is higher than 651.58% of them.
- MNOV has a greater average analyst price target than 212.42% of Healthcare stocks.
Is MNOV a Buy, Hold or Sell? See the POWR Ratings now!